共 208 条
[1]
Theurich S(2013)Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis Crit Rev Oncol Hematol 88 178-186
[2]
Fischmann H(2014)Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease Biol Blood Marrow Transplant 20 370-374
[3]
Chakupurakal G(2014)Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy Biol Blood Marrow Transplant 20 646-654
[4]
Shimabukuro-Vornhagen A(2009)HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen Biol Blood Marrow Transplant 15 454-462
[5]
Chemnitz JM(2009)Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation Biol Blood Marrow Transplant 15 257-265
[6]
Holtick U(2006)Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transplant 38 291-297
[7]
Rothe A(2003)Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin J Clin Oncol 21 506-513
[8]
Scheid C(2007)Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond Leukemia 21 1387-1394
[9]
Hallek M(2014)Antithymocyte globulin in the conditioning regimen: why not? Biol Blood Marrow Transplant 20 597-598
[10]
Skoetz N(2009)Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial Lancet Oncol 10 855-864